NCT02324699View on ClinicalTrials.gov

Corticosteroids With Vedolizumab in Crohn's Disease

PHASE4TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

February 8, 2018

Study Completion Date

February 8, 2018

Conditions
Crohn's Disease
Interventions
DRUG

Prednisone

DRUG

Placebo

DRUG

Vedolizumab

300mg IV over 30 minutes. Both arms will receive vedolizumab at weeks 0, 2, and 6.

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

Sponsors

Collaborators (1)

Takeda
All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

Icahn School of Medicine at Mount Sinai

OTHER